Daniel Jacob Philipson

Daniel Philipson practices at UCLA Medical Plaza in Los Angeles, California.

Daniel Philipson's NPI, 1043605090, was assigned on April 6, 2015. Daniel Philipson graduated from Geisel School Of Medicine At Dartmouth in 2015. Daniel Philipson holds California license A148164.

Daniel Philipson's primary practice is UCLA Medical Plaza, at 5767 W Century Blvd, Los Angeles, CA 90045 in Los Angeles County. The practice phone is (310) 794-1276.

Daniel Philipson's primary practice is UCLA Medical Plaza in Los Angeles, California. Daniel Philipson is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Daniel Philipson to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Philipson practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Daniel Philipson's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Daniel Philipson is board certified in cardiovascular disease by the American Board of Internal Medicine. Daniel Philipson is licensed in California.

Dmand AI lists angioplasty, cardiac catheterization and circulation problems among the conditions Daniel Philipson treats.

CMS data shows 4,636 Medicare services from Daniel Philipson across 28 procedure codes in 2024, for 935 Medicare patients. Medicare paid $374,050 for them.

CMS counts 935 Medicare patients who saw Daniel Philipson in 2024. The largest group is 65 to 74, with 369 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Philipson's median patient age at 64, with 53% women.

In 2024, Daniel Philipson wrote 2,676 Medicare Part D claims for 438 patients. 83% of them were for generic drugs. CMS names the drug for 2,460 of them, across 36 drugs with 11 or more claims each, at $509,798 in total drug cost. In 2023, CMS named 1,324 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Daniel Philipson for performance year 2024, reported through an alternative payment model (APM). Daniel Philipson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Daniel Philipson as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Daniel Philipson, published from 2016 to 2020. Daniel Philipson's most frequent co-authors are Olujimi A. Ajijola, MD, PhD, Jason Sean Bradfield, MD and Zekun Feng, MD.

CMS Open Payments shows 39 general payments to Daniel Philipson from 8 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $645.

Daniel Philipson graduated from Geisel School Of Medicine At Dartmouth in 2015.

Daniel Philipson is in network with 14 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.